For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Oxford Biotherapeutics Ltd

USPTO Granted Patents = 18

CIPO Patents = 3

EPO Patents = 15

Forward Citations = 58

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Christian Rohlff (14 out of 14 patents)

Jonathan Alexander Terrett (11 out of 25 patents)

Alasdair Stamps (5 out of 6 patents)

4. Haichun Huang (2 out of 80 patents)

5. Chin Pan (2 out of 16 patents)

6. Chetana Rao-Naik (2 out of 12 patents)

7. James Edward Ackroyd (2 out of 2 patents)

8. Erika Meaddough (2 out of 2 patents)

9. Heidi N Leblanc (1 out of 22 patents)

10. Bingliang Chen (1 out of 13 patents)

11. Sarah Lee Pogue (1 out of 18 patents)

12. Michelle Renee Kuhne (1 out of 11 patents)

13. Rachel L Dusek (1 out of 1 patent)

14. Arnima Bisht (1 out of 1 patent)

15. Livija Deban (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 11673963 - CRTAM antibodies and methods of treating cancer (2023-06-13),

2. 10982005 - Antibodies to bone marrow stromal antigen 1 (2021-04-20),

3. 10239956 - Nucleic acid encoding bone marrow stromal antigen 1 antibody (2019-03-26),

4. 10081682 - Conjugated antibodies against LY75 for the treatment of cancer (2018-09-25),

5. 9932411 - Antibodies (2018-04-03),

6. 9903872 - Identification of protein associated with hepatocellular carcinoma, gliobastoma and lung cancer (2018-02-27),

7. 9732160 - Methods of treating acute myeloid leukemia with antibodies to bone marrow stromal antigen 1 (2017-08-15),

8. 9447178 - Therapeutic and diagnostic target (2016-09-20),

9. 9228023 - Anti-ROR1 antibodies and methods of use for treatment of cancer (2016-01-05),

10. 9200055 - Protein (2015-12-01),

11. 9181339 - Antibodies specific to cadherin-17 (2015-11-10),

12. 9175092 - Antibodies to bone marrow stromal antigen 1 (2015-11-03),

13. 8652478 - Method for treating cancer by administering antibody to ephrin type-A receptor 7 (2014-02-18),

14. 8540998 - Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents (2013-09-24),

15. 8535677 - Antibody drug conjugate treatment of colorectal cancer (2013-09-17),

Oxford BioTherapeutics is a biotechnology company focused on discovering and developing innovative antibody-based therapies for the treatment of cancer. With expertise in target discovery, antibody generation, and oncology research, the company seeks to improve the lives of cancer patients through the advancement of novel therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

18 Patents

#12 in Abingdon

#992 in United Kingdom

#33,182 in the World

Abingdon, United Kingdom

Oxford Biotherapeutics Ltd

Forward Citations = 58

17 inventors:

Christian Rohlff (14 out of 14 patents)

Jonathan Alexander Terrett (11 out of 25 patents)

Alasdair Stamps (5 out of 6 patents)

4. Haichun Huang (2 out of 80 patents)

5. Chin Pan (2 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…